AU6316400A - Erythromycin a derivatives - Google Patents
Erythromycin a derivativesInfo
- Publication number
- AU6316400A AU6316400A AU63164/00A AU6316400A AU6316400A AU 6316400 A AU6316400 A AU 6316400A AU 63164/00 A AU63164/00 A AU 63164/00A AU 6316400 A AU6316400 A AU 6316400A AU 6316400 A AU6316400 A AU 6316400A
- Authority
- AU
- Australia
- Prior art keywords
- erythromycin
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP22355599 | 1999-08-06 | ||
| JP11/223555 | 1999-08-06 | ||
| PCT/JP2000/005145 WO2001010879A1 (en) | 1999-08-06 | 2000-07-31 | Erythromycin a derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU6316400A true AU6316400A (en) | 2001-03-05 |
Family
ID=16800004
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU63164/00A Abandoned AU6316400A (en) | 1999-08-06 | 2000-07-31 | Erythromycin a derivatives |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU6316400A (en) |
| WO (1) | WO2001010879A1 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1638549A4 (en) * | 2003-03-10 | 2011-06-15 | Optimer Pharmaceuticals Inc | NEW ANTIBACTERIAL AGENTS |
| WO2006035301A2 (en) * | 2004-09-27 | 2006-04-06 | Ranbaxy Laboratories Limited | Erythromycin a derivatives as antibacterial agents |
| JP6437523B2 (en) | 2013-04-04 | 2018-12-12 | プレジデント アンド フェローズ オブ ハーバード カレッジ | Macrolides and methods for their preparation and use |
| CN106998685A (en) * | 2014-10-08 | 2017-08-01 | 哈佛大学的校长及成员们 | 14 yuan of ketone lactones and its preparation and application |
| EP3273969A4 (en) | 2015-03-25 | 2018-11-21 | President and Fellows of Harvard College | Macrolides with modified desosamine sugars and uses thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2727969B1 (en) * | 1994-12-09 | 1997-01-17 | Roussel Uclaf | NOVEL ERYTHROMYCIN DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICAMENTS |
| FR2745290B1 (en) * | 1996-02-28 | 1998-04-03 | Roussel Uclaf | NOVEL ERYTHROMYCIN DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICAMENTS |
| US6140479A (en) * | 1997-03-24 | 2000-10-31 | Taisho Pharmaceuticals Co., Ltd. | Erythromycin a derivatives |
-
2000
- 2000-07-31 AU AU63164/00A patent/AU6316400A/en not_active Abandoned
- 2000-07-31 WO PCT/JP2000/005145 patent/WO2001010879A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001010879A1 (en) | 2001-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU6314900A (en) | Biarylurea derivatives | |
| AU6714700A (en) | Cyclopropylindole derivatives | |
| AUPQ376399A0 (en) | A structural member | |
| AU9277698A (en) | 9-amino-3-keto erythromycin derivatives | |
| AU8018200A (en) | A knowledge-engineering protocol-suite | |
| AU4473097A (en) | Erythromycin a derivatives | |
| NZ513998A (en) | Erythromycin derivatives | |
| AU6183700A (en) | Erythromycin a derivatives | |
| AU7952800A (en) | 2-alkoxybenzene derivatives | |
| AU6262300A (en) | Indolinylamide derivatives | |
| AU6421398A (en) | Erythromycin a derivatives | |
| AU9646098A (en) | Erythromycin a derivatives | |
| AU8925398A (en) | 3-descladinose 6-o-substituded erythromycin derivatives | |
| AUPQ215199A0 (en) | A barrier | |
| AU4472897A (en) | Erythromycin a derivatives | |
| AU6183800A (en) | Erythromycin a derivatives | |
| AU6316400A (en) | Erythromycin a derivatives | |
| AU6932098A (en) | Erythromycin derivatives | |
| AU1558300A (en) | 1-cycloalkylpyrazoyl-benzoyl derivatives | |
| AU1504899A (en) | Erythromycin derivatives | |
| AU6748400A (en) | A single-compiler architecture | |
| AU4222797A (en) | Erythromycin a derivatives | |
| AU5666800A (en) | Difuropyrone derivatives | |
| AU4472797A (en) | Erythromycin a derivatives | |
| AU4472697A (en) | Erythromycin a derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |